News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
86 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21902)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (138)
2 (86)
3 (59)
8 (97)
9 (101)
10 (84)
11 (105)
12 (56)
15 (90)
16 (125)
17 (106)
18 (118)
19 (57)
22 (108)
23 (101)
24 (100)
25 (139)
26 (75)
29 (161)
30 (126)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Drug Development
Cartesian Gets Phase II Win in Myasthenia Gravis, Looks to Raise $130M Through Financing
Cartesian Therapeutics’ mRNA CAR-T therapy met its primary endpoint in a mid-stage trial for the chronic autoimmune disorder and expects to raise $130 million via private placement equity financing.
July 2, 2024
·
2 min read
·
Kate Goodwin
biomodal Files Patent Infringement Lawsuit Against New England Biolabs
July 2, 2024
·
2 min read
Drug Development
Creative Proteomics Elevates Protein Research with Innovative Crosslinking Protein Interaction Analysis Service
July 2, 2024
·
2 min read
Aurigene Pharmaceutical Services Limited, a global CRDMO, and Edity announce a strategic collaboration in cell therapy
Aurigene will provide cell therapy discovery services to Edity to support the latter’s clinical development
July 2, 2024
·
3 min read
Deals
Tobin Scientific Acquires BioRepository Resources
July 2, 2024
·
2 min read
Press Releases
Kye Pharmaceuticals Announces the Availability of QUILLIVANT® ER Chewable Tablets for the Treatment of Children With ADHD
July 2, 2024
·
5 min read
Press Releases
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle (“VAN”)
July 2, 2024
·
6 min read
Press Releases
Valcare Medical, Inc. Announces Formation of Scientific Advisory Board with Renowned Mitral Valve Experts
July 2, 2024
·
6 min read
Press Releases
AbbVie to Host Second-Quarter 2024 Earnings Conference Call
July 2, 2024
·
1 min read
Drug Development
CARVYKTI® meaningful improvement in overall survival in landmark CARTITUDE-4 study
July 2, 2024
·
26 min read
Previous
2 of 9
Next
